Nested Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Nested Therapeutics?

Nested Therapeutics has 6 investors including Avidity Partners And Foresite Capital.

Q: How much funding has Nested Therapeutics raised to date?

Nested Therapeutics has raised obfuscated.

Overview

Nested Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Nested Therapeutics

CB Rank

38294

Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.

Founded

obfuscation

Private

Series A

Cambridge, Massachusetts, United States

11-50

www.nestedtx.com

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Klaus Hoeflich: Chief Scientific Officer and Co-Founder

Details

Legal Name

Nested Therapeutics

Operating Status

Active

Company Type

For Profit

Founders

Klaus Hoeflich

About the Company

Nested Therapeutics is a Cambridge-based VC-backed stealth biotech company. The company's focus is on finding and creating new precision oncology small-molecule drugs targeted toward cancer genes. Nested Therapeutics was established in 2021 in Cambridge, Massachusetts.

Phone Number

617-468-4292

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

NST-628

A pan-RAF/MEK molecular glue designed to inhibit the RAS/MAPK pathway in MAPK-driven solid tumors, including brain-penetrant applications.

Mutation-Selective Program Targeting the p53 Pathway

A drug discovery program developing allosteric molecules that selectively bind novel cryptic pockets in mutated p53 transcriptional regulators in cancer.

Research & Development

Nested Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Nested Therapeutics	5	obfuscated obfuscation	Goldman Sachs Asset Management	Series A
obfuscated obfuscation	Series A - Nested Therapeutics	5	obfuscated obfuscation	Goldman Sachs Asset Management	Series A
obfuscated obfuscation	Series A - Nested Therapeutics	5	obfuscated obfuscation	Goldman Sachs Asset Management	Series A
obfuscated obfuscation	Series A - Nested Therapeutics	5	obfuscated obfuscation	Goldman Sachs Asset Management	Series A
obfuscated obfuscation	Series A - Nested Therapeutics	5	obfuscated obfuscation	Goldman Sachs Asset Management	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Nested Therapeutics	5	obfuscated obfuscation	Goldman Sachs Asset Management	Series A
obfuscated obfuscation	Series A - Nested Therapeutics	5	obfuscated obfuscation	Goldman Sachs Asset Management	Series A
obfuscated obfuscation	Series A - Nested Therapeutics	5	obfuscated obfuscation	Goldman Sachs Asset Management	Series A
obfuscated obfuscation	Series A - Nested Therapeutics	5	obfuscated obfuscation	Goldman Sachs Asset Management	Series A
obfuscated obfuscation	Series A - Nested Therapeutics	5	obfuscated obfuscation	Goldman Sachs Asset Management	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Avidity Partners	—	Series A - Nested Therapeutics	—
Avidity Partners	—	Series A - Nested Therapeutics	—
Avidity Partners	—	Series A - Nested Therapeutics	—
Avidity Partners	—	Series A - Nested Therapeutics	—
Avidity Partners	—	Series A - Nested Therapeutics	—